PPP1R12A and neoplasm: Our observation that cancer-related pathways are upregulated in HCC upon MYPT1 silencing is the results of the higher expression and hyperactivation of PRMT5, which suppresses gene and protein expression of several tumor suppressors or increasing that of potential oncogenes.